NCT05423652 (ACCUMEN-POCUS) is a NA clinical trial of Lung point of care ultrasound in COPD, sponsored by Michelle Grinman.

Who is sponsoring NCT05423652?

NCT05423652 is sponsored by Michelle Grinman.

What drugs are being tested in NCT05423652?

Interventions in NCT05423652: Lung point of care ultrasound, PRESUNA software.

What condition does NCT05423652 study?

NCT05423652 studies COPD, CHF, Pneumonia.

Is NCT05423652 still recruiting?

NCT05423652 is currently active, enrolled. Last updated 2 April 2025.

Last reviewed 2025-04-02 · How we verify

NCT05423652: ACCUMEN-POCUS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound

Active, enrolled NA Last updated 2 April 2025

What this trial tests

NA trial testing Lung point of care ultrasound in COPD in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

16 October 2023

Primary endpoint
31 March 2025

30 September 2025

Quick facts

Lead sponsor	Michelle Grinman
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	20
Start date	16 October 2023
Primary completion	31 March 2025
Estimated completion	30 September 2025
Sites	1 location across Canada

Drugs / interventions tested

Lung point of care ultrasound
PRESUNA software

Conditions studied

COPD — all drugs for COPD →
CHF — all drugs for CHF →
Pneumonia — all drugs for Pneumonia →

Sponsor

Michelle Grinman

Who can join

18 and older, any sex, with COPD or CHF. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-center, two-arm, parallel, randomized controlled trial comparing enhanced daily assessments for patients with COPD and/or CHF using point of care ultrasound with PRESUNA software (POCUS-PRESUNA) versus standard care provided by home-based acute care through a tertiary acute care medical teaching hospital. The objectives are to evaluate POCUS-PRESUNA on improving patient experience, provider experience, improve healthcare utilization/costs, and to test the feasibility of incorporating longitudinal POCUS assessments in home-based acute care via remotely acquired images by non-physicians.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Aiding Chronic Obstructive Pulmonary Disease and Congestive Heart Failure Ultrasound-Guided Management Through Enhanced Point-of-Care Ultrasound (ACCUMEN-POCUS): Protocol for a Randomized Controlled Trial.
Grinman MN, Nakhla P, Reid S, Moon D, et al · · 2025 · PMID 40987446 · DOI 10.2196/76186

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05423652 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Michelle Grinman
Last refreshed: 2 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05423652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing